San Diego, CA, United States of America

Haixia Wang

This inventor holds 10 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Takeda Pharmaceutical Company Limited, Cardurion Pharmaceuticals, LLC, Exelixis, Inc.. Active years: 2009-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Haixia Wang. Retrieved from https://idiyas.com/inventor/haixia-wang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 80.0

 

Average Co-Inventor Count = 8.0

ph-index = 3

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 2009-2021

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Haixia Wang - Innovative Inventor from San Diego

Introduction: Haixia Wang is a pioneering inventor based in San Diego, CA, known for her groundbreaking contributions to the field of technology and innovation.

Latest Patents: Haixia Wang holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing her diverse range of expertise and creativity.

Career Highlights: With a background in engineering and a passion for problem-solving, Haixia Wang has led numerous successful projects that have revolutionized industries and improved people's lives.

Collaborations: Throughout her career, Haixia Wang has collaborated with top research institutions, leading companies, and talented individuals to bring her innovative ideas to life and make a lasting impact on society.

Conclusion: Haixia Wang's dedication to innovation and her relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…